mastodon.xyz is one of the many independent Mastodon servers you can use to participate in the fediverse.
A Mastodon instance, open to everyone, but mainly English and French speaking.

Administered by:

Server stats:

824
active users

#lp_8_1

7 posts1 participant0 posts today
Mike Honey<p>Here's the latest variant picture for Europe (excluding the UK), to early March.</p><p>The XEC.* variant remains dominant, but it has declined to around 31% frequency. </p><p>The LP.8.1.* variant grew to around 23%.</p><p>Note the recent sample volumes are very low, so this might not be a representative picture.</p><p><a href="https://aus.social/tags/COVID19" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>COVID19</span></a> <a href="https://aus.social/tags/EUR" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>EUR</span></a> <a href="https://aus.social/tags/XEC" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>XEC</span></a> <a href="https://aus.social/tags/LP_8_1" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>LP_8_1</span></a> <br>🧵</p>
Mike Honey<p>Here's the latest variant picture for the United Kingdom, to early March.</p><p>The XEC.* variant remains dominant, but it is generally declining to around 50% frequency. </p><p>The LP.8.1.* variant is slowly growing, at around 15%. </p><p><a href="https://aus.social/tags/COVID19" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>COVID19</span></a> <a href="https://aus.social/tags/UK" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>UK</span></a> <a href="https://aus.social/tags/XEC" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>XEC</span></a> <a href="https://aus.social/tags/LP_8_1" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>LP_8_1</span></a><br>🧵</p>
Mike Honey<p>Here's the latest variant picture for Canada. Some further samples been shared from Ontario but they are thin and patchy compared to the earlier volumes.</p><p>The current picture is that XEC.* is stall dominant at 30-40%, with LP.8.1.* challenging at around 24%. The JN.1.* + FLiRT lineages are at 10-12%.</p><p><a href="https://aus.social/tags/COVID19" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>COVID19</span></a> <a href="https://aus.social/tags/Canada" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Canada</span></a> <a href="https://aus.social/tags/XEC" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>XEC</span></a> <a href="https://aus.social/tags/LP_8_1" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>LP_8_1</span></a><br>🧵</p>
Mike Honey<p>Here's the latest variant picture for the United States, to mid-March.</p><p>The LP.8.1.* variant has continued to grow steadily to around 49%.</p><p>The XEC.* variant continued to fall, down to around 19%.</p><p><a href="https://aus.social/tags/COVID19" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>COVID19</span></a> <a href="https://aus.social/tags/USA" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>USA</span></a> <a href="https://aus.social/tags/XEC" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>XEC</span></a> <a href="https://aus.social/tags/LP_8_1" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>LP_8_1</span></a><br>🧵</p>
Mike Honey<p>Here's the latest variant picture for New Zealand, to mid-March.</p><p>DeFLuQE variants continue to dominate, with the LP.8.1.* variant up to 18%, competing with XEC.*.</p><p><a href="https://aus.social/tags/COVID19" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>COVID19</span></a> <a href="https://aus.social/tags/NZ" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NZ</span></a> <a href="https://aus.social/tags/DeFLuQE" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>DeFLuQE</span></a> <a href="https://aus.social/tags/XEC" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>XEC</span></a> <a href="https://aus.social/tags/LP_8_1" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>LP_8_1</span></a><br>🧵</p>
Mike Honey<p>Here's the latest variant picture for Australia, to early March.</p><p>XEC.* continues to dominate, although fairly flat at around 50-60%. </p><p>The LP.8.1.* variant grew to around 18%, finally challenging the DeFLuQE variants as the new challenger.</p><p><a href="https://aus.social/tags/COVID19" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>COVID19</span></a> <a href="https://aus.social/tags/Australia" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Australia</span></a> <a href="https://aus.social/tags/XEC" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>XEC</span></a> <a href="https://aus.social/tags/LP_8_1" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>LP_8_1</span></a> <span class="h-card" translate="no"><a href="https://a.gup.pe/u/auscovid19" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@<span>auscovid19</span></a></span> <br>🧵</p>
Mike Honey<p>Here's the latest variant picture with a global scope, to mid- March.</p><p>The LP.8.1.* variant grew to around 38%, taking over dominance from the declining XEC.* variant. </p><p><a href="https://aus.social/tags/COVID19" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>COVID19</span></a> <a href="https://aus.social/tags/Global" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Global</span></a> <a href="https://aus.social/tags/XEC" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>XEC</span></a> <a href="https://aus.social/tags/LP_8_1" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>LP_8_1</span></a><br>🧵</p>
Mike Honey<p>Here's the latest variant picture for Europe (excluding the UK), to early March.</p><p>The XEC.* variant remains dominant, but it has declined to around 48% frequency. </p><p>The LP.8.1.* variant grew recently to 20%, passing the other contenders.</p><p><a href="https://aus.social/tags/COVID19" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>COVID19</span></a> <a href="https://aus.social/tags/EUR" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>EUR</span></a> <a href="https://aus.social/tags/XEC" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>XEC</span></a> <a href="https://aus.social/tags/LP_8_1" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>LP_8_1</span></a> <br>🧵</p>
Mike Honey<p>Here's the latest variant picture for the United Kingdom, to early March.</p><p>The XEC.* variant remains dominant, but it has fallen to around 44% frequency. </p><p>The LP.8.1.* variant grew somewhat to 21%, but then fell back in recent samples to finish at around 17%. </p><p><a href="https://aus.social/tags/COVID19" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>COVID19</span></a> <a href="https://aus.social/tags/UK" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>UK</span></a> <a href="https://aus.social/tags/XEC" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>XEC</span></a> <a href="https://aus.social/tags/LP_8_1" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>LP_8_1</span></a><br>🧵</p>
Mike Honey<p>Here's the latest variant picture for the United States, to early March.</p><p>The LP.8.1.* variant has continued to grow steadily to around 44%.</p><p>The XEC.* variant continued to fall, down to around 24%.</p><p><a href="https://aus.social/tags/COVID19" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>COVID19</span></a> <a href="https://aus.social/tags/USA" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>USA</span></a> <a href="https://aus.social/tags/XEC" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>XEC</span></a> <a href="https://aus.social/tags/LP_8_1" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>LP_8_1</span></a><br>🧵</p>
Mike Honey<p>Here's the latest variant picture for New Zealand.</p><p>DeFLuQE variants continue to dominate, with the LP.8.1.* variant showing some strong recent growth to 24%, apparently overtaking XEC.*.</p><p><a href="https://aus.social/tags/COVID19" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>COVID19</span></a> <a href="https://aus.social/tags/NZ" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NZ</span></a> <a href="https://aus.social/tags/DeFLuQE" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>DeFLuQE</span></a> <a href="https://aus.social/tags/XEC" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>XEC</span></a> <a href="https://aus.social/tags/LP_8_1" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>LP_8_1</span></a><br>🧵</p>
Mike Honey<p>Here's the latest variant picture for Australia.</p><p>XEC.* continues to dominate by early March, although growth is fairly flat at around 50-60%. </p><p>The LP.8.1.* variant grew slowly to around 12%. Globally, this looks like the most likely challenger.</p><p><a href="https://aus.social/tags/COVID19" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>COVID19</span></a> <a href="https://aus.social/tags/Australia" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Australia</span></a> <a href="https://aus.social/tags/XEC" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>XEC</span></a> <a href="https://aus.social/tags/LP_8_1" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>LP_8_1</span></a> <span class="h-card" translate="no"><a href="https://a.gup.pe/u/auscovid19" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@<span>auscovid19</span></a></span> <br>🧵</p>
Mike Honey<p>Here's the latest variant picture with a global scope.</p><p>The XEC.* variant has continued to decline, down to 34% by early March. Meanwhile the LP.8.1.* variant grew to around 28%.</p><p><a href="https://aus.social/tags/COVID19" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>COVID19</span></a> <a href="https://aus.social/tags/Global" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Global</span></a> <a href="https://aus.social/tags/XEC" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>XEC</span></a> <a href="https://aus.social/tags/LP_8_1" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>LP_8_1</span></a><br>🧵</p>
Mike Honey<p>Here's the latest variant picture for the United Kingdom.</p><p>The XEC.* variant remains dominant, but growth has stalled at around 60% frequency. </p><p>The LP.8.1.* variant grew somewhat to 19% frequency, but then fell back in recent samples to finish at around 15%. </p><p><a href="https://aus.social/tags/COVID19" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>COVID19</span></a> <a href="https://aus.social/tags/UK" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>UK</span></a> <a href="https://aus.social/tags/XEC" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>XEC</span></a> <a href="https://aus.social/tags/LP_8_1" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>LP_8_1</span></a><br>🧵</p>
Mike Honey<p>Here's the latest variant picture for the United States.</p><p>The LP.8.1.* variant has continued to grow steadily to around 37%.</p><p>The XEC.* variant continued to fall, down to around 28%.</p><p><a href="https://aus.social/tags/COVID19" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>COVID19</span></a> <a href="https://aus.social/tags/USA" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>USA</span></a> <a href="https://aus.social/tags/XEC" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>XEC</span></a> <a href="https://aus.social/tags/LP_8_1" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>LP_8_1</span></a><br>🧵</p>
Mike Honey<p>Here's the latest variant picture for Canada. Samples have not been shared from Ontario since mid-February, leading to the typical chaotic picture when sample volumes are low.</p><p>There’s been a dramatic recent rise in the JN.1.* + FLiRT lineages, possibly rising to dominance.</p><p><a href="https://aus.social/tags/COVID19" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>COVID19</span></a> <a href="https://aus.social/tags/Canada" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Canada</span></a> <a href="https://aus.social/tags/XEC" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>XEC</span></a> <a href="https://aus.social/tags/LP_8_1" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>LP_8_1</span></a><br>🧵</p>
Mike Honey<p>Here's the latest variant picture for Australia.</p><p>XEC.* continues to dominate, although now declining to around 47%. </p><p>The LP.8.1.* variant grew slowly to around 15%, then fell back in recent samples to 11%. Globally, this looks like the most likely challenger.</p><p><a href="https://aus.social/tags/COVID19" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>COVID19</span></a> <a href="https://aus.social/tags/Australia" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Australia</span></a> <a href="https://aus.social/tags/XEC" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>XEC</span></a> <a href="https://aus.social/tags/LP_8_1" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>LP_8_1</span></a> <span class="h-card" translate="no"><a href="https://a.gup.pe/u/auscovid19" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@<span>auscovid19</span></a></span> <br>🧵</p>
Mike Honey<p>Meanwhile, the XEC.* variant has continued to decline, while the LP.8.1.* variant grew to around 28%.</p><p><a href="https://aus.social/tags/COVID19" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>COVID19</span></a> <a href="https://aus.social/tags/Global" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Global</span></a> <a href="https://aus.social/tags/XEC" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>XEC</span></a> <a href="https://aus.social/tags/LP_8_1" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>LP_8_1</span></a><br>🧵</p>
Mike Honey<p>Here's the latest variant picture for the United Kingdom.</p><p>XEC.* remains dominant, but growth has stalled at around 60-70% frequency. </p><p>The LP.8.1.* variant was flat at around 10-15% frequency. </p><p>There’s a possible rebound underway among the JN.1.* + DeFLuQE variants, but recent sample volumes are too low to be certain.</p><p><a href="https://aus.social/tags/COVID19" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>COVID19</span></a> <a href="https://aus.social/tags/UK" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>UK</span></a> <a href="https://aus.social/tags/XEC" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>XEC</span></a> <a href="https://aus.social/tags/LP_8_1" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>LP_8_1</span></a><br>🧵</p>
Mike Honey<p>Here's the latest variant picture for the United States.</p><p>The XEC.* variant has been overtaken by the LP.8.1.* variant - growing steadily to around 34%.</p><p>There’s a rebound underway among the JN.1.* + FLiRT variants, led by the LB.1.3.1 lineage.</p><p><a href="https://aus.social/tags/COVID19" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>COVID19</span></a> <a href="https://aus.social/tags/USA" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>USA</span></a> <a href="https://aus.social/tags/XEC" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>XEC</span></a> <a href="https://aus.social/tags/LP_8_1" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>LP_8_1</span></a><br>🧵</p>